National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

talcPatient Information
Finely-powdered native hydrous magnesium silicate. When administered into the pleural space, talc initiates an inflammatory reaction, resulting in adhesion of the visceral pleura to the parietal pleura and fibrosis, thereby effectively closing the pleural space and preventing further accumulation of fluid. This agent exhibits no intrinsic antineoplastic activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Sclerosol Intrapleural Aerosol
Sterile Talc Powder
Steritalc



Previous:Tagamet, talabostat mesylate, talactoferrin, talampanel, talaporfin sodium
Next:talotrexin ammonium, Talvesta, tamibarotene, Tamiflu, tamoxifen citrate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov